Our fair value estimate for Ansys is $327 per share, based on its pending deal to be acquired by Synopsys. Ansys shareholders will receive $197 in cash and 0.345 shares of Synopsys stock for each ...
AHRQ's Healthcare Simulation Dictionary, Version 3.0 (PDF, 2 MB), includes 170 definitions of healthcare simulation terms ranging from “avatars” and “manikins” to “gamification” and “virtual reality.” ...
In a recent achievement, DP Technology's hit discovery platform RiDYMO® has successfully designed a cyclic peptide targeting ?-catenin, a historically "undruggable" protein, in just two months. This ...